RSS available
Fact: There is no immunity or protection against The Law of Scoreboards. Did you know: What the media does NOT want you to read is at https://market-ticker.org/nad. You are not signed on; if you are a visitor please register for a free account! |
The Market Ticker Single Post Display (Show in context) |
|
Top | Login | FAQ | Register | Clear Cookie |
User Info | There Are THREE Studies; All Showing Serious Harms; entered at 2021-05-02 13:28:11 | |||
Njca Posts: 274 Registered: 2018-10-16 |
Autoimmune disease drug companies licking their chops. ******* Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity "Here I provide an assessment of potential for human pathogenesis via autoimmunity via exposure, via infection or injection. SAR-CoV-2 spike proteins, and all other SARS-CoV-2 proteins, immunogenic epitopes in each SARS-CoV-2 protein were compared to human proteins in search of high local homologous matching. Only one immunogenic epitope in a SARS-CoV-2 had no homology to human proteins." "Autopsies of Chinese citizens who have died from COVID-19 following SARS-CoV-19 infection show evidence of interstitial changes, suggesting the development of pulmonary fibrosis [1]. This suggests, at least partly, an autoimmunology basis of the pathogenesis of COVID-19." " In SARS, a type of priming of the immune system was observed during animal studies of SARS spike protein-based vaccines leading to increased morbidity and mortality in vaccinated animals who were subsequently exposed to wild SARS virus. The problem, highlighted in two studies, became obvious following post-vaccination challenge with the SARS virus [2]. found that recombinant SARS spike-protein-based vaccines not only failed to provide protection from SARS-CoV infec- tion, but also that the mice experienced increased immunopathology with eosinophilic infiltrates in their lungs. Similarly [3], found that fer- rets previously vaccinated against SARS-CoV also developed a strong inflammatory response in liver tissue (hepatitis). Both studies suspected a cellular immune response." https://www.ncbi.nlm.nih.gov/pmc/article.... 2021-05-02 13:28:11
|